BFR ESS: A randomized phase II trial from the GSF/GETO French group evaluating the impact of interruption versus maintenance of aromatase inhibitors in patients with advanced or metastatic low grade endometrial stromal sarcoma after at least 3 years of th

Affiliation auteurs!!!! Error affiliation !!!!
TitreBFR ESS: A randomized phase II trial from the GSF/GETO French group evaluating the impact of interruption versus maintenance of aromatase inhibitors in patients with advanced or metastatic low grade endometrial stromal sarcoma after at least 3 years of th
Type de publicationJournal Article
Year of Publication2021
AuteursRay-Coquard I.L, Bompas E., Cropet C., Donnat M., Bertucci F., Chaigneau L., Metzger S., Dufresne A., Guillemet C., C. Vassal P, Venat-Bouvet L., Vegas H., Piperno-Neumann S., Fabbro M., Blay J-Y., Dubray-Longeras P., Savoye A.M, Brahmi M., Floquet A.
JournalANNALS OF ONCOLOGY
Volume32
PaginationS772
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2021.08.1264